TY  - GEN
AU  - Krogsgaard,K
AU  - Marcellin,P
AU  - Trepo,C
AU  - Berthelot,P
AU  - Sanchez-Tapias,J M
AU  - Bassendine,M
AU  - Tran,A
AU  - Ouzan,D
AU  - Ring-Larsen,H
AU  - Lindberg,J
AU  - Enriquez,J
AU  - Benhamou,J P
AU  - Bindslev,N
TI  - Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial Group
SN  - 0168-8278
PY  - 1997///0409
KW  - Adult
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Biopsy
KW  - Chronic Disease
KW  - DNA, Viral
KW  - analysis
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Drug Synergism
KW  - Female
KW  - Follow-Up Studies
KW  - Glucocorticoids
KW  - Hepatitis B
KW  - blood
KW  - Hepatitis B Antibodies
KW  - Hepatitis B e Antigens
KW  - immunology
KW  - Hepatitis B virus
KW  - genetics
KW  - Humans
KW  - Interferon-alpha
KW  - Male
KW  - Prednisolone
KW  - Transaminases
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1016/s0168-8278(96)80282-0
ER  -